HikariQ Health
Innovating immunoassay and antibody therapeutics with Q-body technology
Minato, Japan · Founded 2021 · $490K raised
- Headquarters
- Minato
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- hikariq.co.jp
- Total Funding
- $490K
- Last Round
- $490K SeedJan 2023
- Rounds
- 1
About
HikariQ Health is a Tokyo-based biotech startup founded in 2021, spun out of the Tokyo Institute of Technology. The company develops innovative immunoassay methods and antibody drugs based on its proprietary Q-body technology — a fluorescent biosensor that enables wash-free, single-step antigen detection by encapsulating chemicals through antibody structural modification. HikariQ is also applying its Q-body platform to the development of antibody-drug conjugates and antibody pharmaceuticals.
Summary
HikariQ Health is a Biotech company based in Minato, Japan, founded in 2021. It has raised $490K in total across 1 round, most recently a $490K Seed round in Jan 2023. Investors include Coral Capital and 500 Startups Japan.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company

Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.